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Background
Human papillomaviruses (HPVs) are small, non-enveloped
DNA viruses that infect stratified squamous mucosal and
cutaneous epithelia, causing diseases ranging from benign
warts to invasive tumors. Failure of the immune system to
detect and clear persistent HPV infections frequently leads
to the development of oral warts and cancer. HPV infec-
tion has been etiologically linked with oral warts and a
subset of oral squamous cell carcinoma, particularly in
HIV infected patients. The incidence of HPV-related oral
lesions is increased in HIV+ subjects on highly active anti-
retroviral therapy (HAART). We previously showed that
tumor cells in oral carcinoma in situ (CIS) lesions overex-
press human beta-defensin-3 (hBD-3), an antimicrobial
peptide with immunomodulatory capabilities. Expression
of hBD-3 in CIS contributes to the local pro-tumor
immune response by selectively chemoattracting tumor-
associated macrophages and by enhancing tumor develop-
ment and progression.
Results
To elucidate mechanisms by which high-risk HPV could
evade immune detection and clearing via infected epithe-
lial cells, we investigated if oncoproteins E6 and E7 derived
from high-risk HPV-16 modulate the innate immune
response of infected epithelial cells and the role of HPV-
induced gene expression in orchestrating local immunity.
We have found that cancer cells of HPV-related oral and
oropharyngeal squamous cell carcinoma biopsies overpro-
duce hBD-3. Introduction of an expression vector produ-
cing HPV-16 E6 or E7 oncogene into oral squamous
cancer cell lines or primary oral epithelial cells increases
the levels of hBD-3 mRNA and peptide. However, E6
derived from the low-risk HPV-11 is significantly less
potent in promoting hBD-3 expression. Combination of
oncogenic E6 and E7 in oral epithelial cells also shows
reduced induction of hBD-3. Furthermore, the transactiv-
ity of an hBD-3 luciferase promoter construct is differen-
tially stimulated by oncogenic E6 and E7 compared with
MEKK1, a known inducer of hBD-3 expression. Although
the pharmacological inhibitors for MAPK and PI3K
reduce the transactivity of a 2.5 kb hBD-3 promoter repor-
ter, they do not exhibit the inhibitory effect on the promo-
t e rr e p o r t e rc o n t a i n i n ga4 5 0b p3 ’-regulatory region.
These data suggest that high-risk and low-risk early genes
of HPV differentially modulate hBD-3 expression in oral
epithelial cells.
Conclusion
Our results suggest that oncoproteins of high-risk HPV
strains induce higher levels of hBD-3 expression com-
pared with early genes of low-risk HPV. The oncogenic
E6 and E7 genes may contribute to overexpression of
hBD-3 in the early oral lesion, which then leads to
recruitment of tumor-associated macrophages to further
develop and promote the progression of cancer.
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